Table of Content

Chapter 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
Chapter 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
Chapter 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of genetic diseases
3.4.1.2. Increase in prevalence of cancer
3.4.1.3. Rise in the number of genetic testing.
3.4.2. Restraints
3.4.2.1. High cost of genetic testing
3.4.3. Opportunities
3.4.3.1. Increase in number of adoptions of key strategies.
Chapter 4: GENETIC TESTING MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Predictive and Presymptomatic Testing
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Carrier Testing
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Prenatal and Newborn Testing
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Diagnostic Testing
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. Pharmacogenomic Testing
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
4.7. Others
4.7.1. Key market trends, growth factors and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market share analysis by country
Chapter 5: GENETIC TESTING MARKET, BY TECHNOLOGY
5.1. Overview
5.1.1. Market size and forecast
5.2. Cytogenetic testing
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Biochemical testing
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Molecular testing
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
Chapter 6: GENETIC TESTING MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Cancer diagnosis
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Genetic disease diagnosis
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
Chapter 7: GENETIC TESTING MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Technology
7.2.4. Market size and forecast, by Application
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Type
7.2.5.1.2. Market size and forecast, by Technology
7.2.5.1.3. Market size and forecast, by Application
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Type
7.2.5.2.2. Market size and forecast, by Technology
7.2.5.2.3. Market size and forecast, by Application
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Type
7.2.5.3.2. Market size and forecast, by Technology
7.2.5.3.3. Market size and forecast, by Application
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Technology
7.3.4. Market size and forecast, by Application
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Type
7.3.5.1.2. Market size and forecast, by Technology
7.3.5.1.3. Market size and forecast, by Application
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Type
7.3.5.2.2. Market size and forecast, by Technology
7.3.5.2.3. Market size and forecast, by Application
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Type
7.3.5.3.2. Market size and forecast, by Technology
7.3.5.3.3. Market size and forecast, by Application
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Type
7.3.5.4.2. Market size and forecast, by Technology
7.3.5.4.3. Market size and forecast, by Application
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Type
7.3.5.5.2. Market size and forecast, by Technology
7.3.5.5.3. Market size and forecast, by Application
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Type
7.3.5.6.2. Market size and forecast, by Technology
7.3.5.6.3. Market size and forecast, by Application
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Technology
7.4.4. Market size and forecast, by Application
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Type
7.4.5.1.2. Market size and forecast, by Technology
7.4.5.1.3. Market size and forecast, by Application
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Type
7.4.5.2.2. Market size and forecast, by Technology
7.4.5.2.3. Market size and forecast, by Application
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Type
7.4.5.3.2. Market size and forecast, by Technology
7.4.5.3.3. Market size and forecast, by Application
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Type
7.4.5.4.2. Market size and forecast, by Technology
7.4.5.4.3. Market size and forecast, by Application
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Type
7.4.5.5.2. Market size and forecast, by Technology
7.4.5.5.3. Market size and forecast, by Application
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Type
7.4.5.6.2. Market size and forecast, by Technology
7.4.5.6.3. Market size and forecast, by Application
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Technology
7.5.4. Market size and forecast, by Application
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Type
7.5.5.1.2. Market size and forecast, by Technology
7.5.5.1.3. Market size and forecast, by Application
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Type
7.5.5.2.2. Market size and forecast, by Technology
7.5.5.2.3. Market size and forecast, by Application
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Type
7.5.5.3.2. Market size and forecast, by Technology
7.5.5.3.3. Market size and forecast, by Application
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Type
7.5.5.4.2. Market size and forecast, by Technology
7.5.5.4.3. Market size and forecast, by Application
Chapter 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
Chapter 9: COMPANY PROFILES
9.1. Abbott Laboratories
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.2. Bio-Rad Laboratories, Inc. 
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.3. Myriad Genetics, Inc.
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. Danaher Corporation
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.5. F. Hoffmann-La Roche Ltd.
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.6. Illumina, Inc.
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. Thermo Fisher Scientific, Inc.
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.8. Qiagen N.V
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.9. CSL Limited
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.10. Luminex Corporation
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio



List of Figures

LIST OF FIGURES
FIGURE 01. GENETIC TESTING MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF GENETIC TESTING MARKET,2022-2032
FIGURE 03. TOP IMPACTING FACTORS IN GENETIC TESTING MARKET (2022 TO 2032)
FIGURE 04. TOP INVESTMENT POCKETS IN GENETIC TESTING MARKET (2023-2032)
FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 06. LOW THREAT OF NEW ENTRANTS
FIGURE 07. LOW THREAT OF SUBSTITUTES
FIGURE 08. LOW INTENSITY OF RIVALRY
FIGURE 09. LOW BARGAINING POWER OF BUYERS
FIGURE 10. GLOBAL GENETIC TESTING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. GENETIC TESTING MARKET, BY TYPE, 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR PREDICTIVE AND PRESYMPTOMATIC TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR CARRIER TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR PRENATAL AND NEWBORN TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR DIAGNOSTIC TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR PHARMACOGENOMIC TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. GENETIC TESTING MARKET, BY TECHNOLOGY, 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR CYTOGENETIC TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR BIOCHEMICAL TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR MOLECULAR TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. GENETIC TESTING MARKET, BY APPLICATION, 2022 AND 2032(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR CANCER DIAGNOSIS, BY COUNTRY 2022 AND 2032(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR GENETIC DISEASE DIAGNOSIS, BY COUNTRY 2022 AND 2032(%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 26. GENETIC TESTING MARKET BY REGION, 2022 AND 2032(%)
FIGURE 27. U.S. GENETIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 28. CANADA GENETIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 29. MEXICO GENETIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 30. GERMANY GENETIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 31. FRANCE GENETIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 32. UK GENETIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 33. ITALY GENETIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 34. SPAIN GENETIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 35. REST OF EUROPE GENETIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 36. JAPAN GENETIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 37. CHINA GENETIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 38. INDIA GENETIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 39. AUSTRALIA GENETIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 40. SOUTH KOREA GENETIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 41. REST OF ASIA-PACIFIC GENETIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 42. BRAZIL GENETIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 43. SAUDI ARABIA GENETIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 44. SOUTH AFRICA GENETIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 45. REST OF LAMEA GENETIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 47. COMPETITIVE DASHBOARD
FIGURE 48. COMPETITIVE HEATMAP: GENETIC TESTING MARKET
FIGURE 49. TOP PLAYER POSITIONING, 2022
FIGURE 50. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
FIGURE 51. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 52. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 53. BIO-RAD LABORATORIES, INC.?: NET SALES, 2020-2022 ($MILLION)
FIGURE 54. BIO-RAD LABORATORIES, INC.?: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 55. BIO-RAD LABORATORIES, INC.?: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 56. MYRIAD GENETICS, INC.: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 57. MYRIAD GENETICS, INC.: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 58. DANAHER CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 59. DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 60. DANAHER CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 61. F. HOFFMANN-LA ROCHE LTD.: SALES REVENUE, 2020-2022 ($MILLION)
FIGURE 62. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 63. ILLUMINA, INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 64. ILLUMINA, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 65. ILLUMINA, INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 66. THERMO FISHER SCIENTIFIC, INC.: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 67. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 68. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 69. QIAGEN N.V: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 70. QIAGEN N.V: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 71. CSL LIMITED: SALES REVENUE, 2020-2022 ($MILLION)
FIGURE 72. CSL LIMITED: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 73. CSL LIMITED: REVENUE SHARE BY REGION, 2022 (%)

List of Tables

LIST OF TABLES
TABLE 01. GLOBAL GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 02. GENETIC TESTING MARKET FOR PREDICTIVE AND PRESYMPTOMATIC TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 03. GENETIC TESTING MARKET FOR CARRIER TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 04. GENETIC TESTING MARKET FOR PRENATAL AND NEWBORN TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 05. GENETIC TESTING MARKET FOR DIAGNOSTIC TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 06. GENETIC TESTING MARKET FOR PHARMACOGENOMIC TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 07. GENETIC TESTING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 08. GLOBAL GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 09. GENETIC TESTING MARKET FOR CYTOGENETIC TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 10. GENETIC TESTING MARKET FOR BIOCHEMICAL TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 11. GENETIC TESTING MARKET FOR MOLECULAR TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 12. GLOBAL GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 13. GENETIC TESTING MARKET FOR CANCER DIAGNOSIS, BY REGION, 2022-2032 ($MILLION)
TABLE 14. GENETIC TESTING MARKET FOR GENETIC DISEASE DIAGNOSIS, BY REGION, 2022-2032 ($MILLION)
TABLE 15. GENETIC TESTING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 16. GENETIC TESTING MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 18. NORTH AMERICA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 19. NORTH AMERICA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 20. NORTH AMERICA GENETIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 21. U.S. GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 22. U.S. GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 23. U.S. GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 24. CANADA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 25. CANADA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 26. CANADA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 27. MEXICO GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 28. MEXICO GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 29. MEXICO GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 30. EUROPE GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 31. EUROPE GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 32. EUROPE GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 33. EUROPE GENETIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 34. GERMANY GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 35. GERMANY GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 36. GERMANY GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 37. FRANCE GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 38. FRANCE GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 39. FRANCE GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 40. UK GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 41. UK GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 42. UK GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 43. ITALY GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 44. ITALY GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 45. ITALY GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 46. SPAIN GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 47. SPAIN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 48. SPAIN GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 49. REST OF EUROPE GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 50. REST OF EUROPE GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 51. REST OF EUROPE GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 53. ASIA-PACIFIC GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 54. ASIA-PACIFIC GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 55. ASIA-PACIFIC GENETIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 56. JAPAN GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 57. JAPAN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 58. JAPAN GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 59. CHINA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 60. CHINA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 61. CHINA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 62. INDIA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 63. INDIA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 64. INDIA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 65. AUSTRALIA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 66. AUSTRALIA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 67. AUSTRALIA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 68. SOUTH KOREA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 69. SOUTH KOREA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 70. SOUTH KOREA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 74. LAMEA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 75. LAMEA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 76. LAMEA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 77. LAMEA GENETIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 78. BRAZIL GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 79. BRAZIL GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 80. BRAZIL GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 81. SAUDI ARABIA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 82. SAUDI ARABIA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 83. SAUDI ARABIA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 84. SOUTH AFRICA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 85. SOUTH AFRICA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 86. SOUTH AFRICA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 87. REST OF LAMEA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 88. REST OF LAMEA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 89. REST OF LAMEA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 90. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 91. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 92. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 93. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 94. BIO-RAD LABORATORIES, INC.?: KEY EXECUTIVES
TABLE 95. BIO-RAD LABORATORIES, INC.?: COMPANY SNAPSHOT
TABLE 96. BIO-RAD LABORATORIES, INC.?: PRODUCT SEGMENTS
TABLE 97. BIO-RAD LABORATORIES, INC.?: PRODUCT PORTFOLIO
TABLE 98. MYRIAD GENETICS, INC.: KEY EXECUTIVES
TABLE 99. MYRIAD GENETICS, INC.: COMPANY SNAPSHOT
TABLE 100. MYRIAD GENETICS, INC.: SERVICE SEGMENTS
TABLE 101. MYRIAD GENETICS, INC.: PRODUCT PORTFOLIO
TABLE 102. MYRIAD GENETICS, INC.: KEY STRATERGIES
TABLE 103. DANAHER CORPORATION: KEY EXECUTIVES
TABLE 104. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 105. DANAHER CORPORATION: PRODUCT SEGMENTS
TABLE 106. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 107. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
TABLE 108. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
TABLE 109. F. HOFFMANN-LA ROCHE LTD.: PRODUCT SEGMENTS
TABLE 110. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
TABLE 111. ILLUMINA, INC.: KEY EXECUTIVES
TABLE 112. ILLUMINA, INC.: COMPANY SNAPSHOT
TABLE 113. ILLUMINA, INC.: PRODUCT SEGMENTS
TABLE 114. ILLUMINA, INC.: PRODUCT PORTFOLIO
TABLE 115. ILLUMINA, INC.: KEY STRATERGIES
TABLE 116. THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
TABLE 117. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
TABLE 118. THERMO FISHER SCIENTIFIC, INC.: PRODUCT SEGMENTS
TABLE 119. THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
TABLE 120. QIAGEN N.V: KEY EXECUTIVES
TABLE 121. QIAGEN N.V: COMPANY SNAPSHOT
TABLE 122. QIAGEN N.V: PRODUCT SEGMENTS
TABLE 123. QIAGEN N.V: PRODUCT PORTFOLIO
TABLE 124. CSL LIMITED: KEY EXECUTIVES
TABLE 125. CSL LIMITED: COMPANY SNAPSHOT
TABLE 126. CSL LIMITED: PRODUCT SEGMENTS
TABLE 127. CSL LIMITED: PRODUCT PORTFOLIO
TABLE 128. LUMINEX CORPORATION: KEY EXECUTIVES
TABLE 129. LUMINEX CORPORATION: COMPANY SNAPSHOT
TABLE 130. LUMINEX CORPORATION: PRODUCT SEGMENTS
TABLE 131. LUMINEX CORPORATION: PRODUCT PORTFOLIO